Publication Information

{'id': 'https://openalex.org/W4393989242', 'doi': 'https://doi.org/10.1158/1538-7445.am2024-ct271', 'title': 'Abstract CT271: Neoadjuvant targeted therapy in stage I-III HER2-mutant lobular breast cancer', 'display_name': 'Abstract CT271: Neoadjuvant targeted therapy in stage I-III HER2-mutant lobular breast cancer', 'publication_year': 2024, 'publication_date': '2024-04-05', 'ids': {'openalex': 'https://openalex.org/W4393989242', 'doi': 'https://doi.org/10.1158/1538-7445.am2024-ct271'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2024-ct271', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5057978359', 'display_name': 'Laura C. Kennedy', 'orcid': 'https://orcid.org/0000-0001-8958-7909'}, 'institutions': [{'id': 'https://openalex.org/I901861585', 'display_name': 'Vanderbilt University Medical Center', 'ror': 'https://ror.org/05dq2gs74', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210162197', 'https://openalex.org/I901861585']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Laura C. Kennedy', 'raw_affiliation_strings': ['1Vanderbilt University Medical Center, Nashville, TN;'], 'affiliations': [{'raw_affiliation_string': '1Vanderbilt University Medical Center, Nashville, TN;', 'institution_ids': ['https://openalex.org/I901861585']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061962242', 'display_name': 'Nisha Unni', 'orcid': 'https://orcid.org/0000-0003-1549-4720'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nisha Unni', 'raw_affiliation_strings': ['2University of Texas Southwestern, Dallas, TX.'], 'affiliations': [{'raw_affiliation_string': '2University of Texas Southwestern, Dallas, TX.', 'institution_ids': ['https://openalex.org/I867280407']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020373259', 'display_name': 'Ariella B. Hanker', 'orcid': 'https://orcid.org/0000-0002-8655-8341'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ariella B. Hanker', 'raw_affiliation_strings': ['2University of Texas Southwestern, Dallas, TX.'], 'affiliations': [{'raw_affiliation_string': '2University of Texas Southwestern, Dallas, TX.', 'institution_ids': ['https://openalex.org/I867280407']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5043946489', 'display_name': 'Carlos L. Arteaga', 'orcid': 'https://orcid.org/0000-0003-0870-9586'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Carlos L. Arteaga', 'raw_affiliation_strings': ['2University of Texas Southwestern, Dallas, TX.'], 'affiliations': [{'raw_affiliation_string': '2University of Texas Southwestern, Dallas, TX.', 'institution_ids': ['https://openalex.org/I867280407']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 84}, 'biblio': {'volume': '84', 'issue': '7_Supplement', 'first_page': 'CT271', 'last_page': 'CT271'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9926, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9926, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11752', 'display_name': 'Cancer Treatment and Pharmacology', 'score': 0.9914, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10183', 'display_name': 'Breast Cancer Treatment Studies', 'score': 0.9902, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/neoadjuvant-therapy', 'display_name': 'Neoadjuvant Therapy', 'score': 0.5697365}, {'id': 'https://openalex.org/keywords/targeted-therapy', 'display_name': 'Targeted Therapy', 'score': 0.49512926}], 'concepts': [{'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.71333504}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.67154545}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.6089784}, {'id': 'https://openalex.org/C2778292576', 'wikidata': 'https://www.wikidata.org/wiki/Q6991934', 'display_name': 'Neoadjuvant therapy', 'level': 4, 'score': 0.5697365}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.54145736}, {'id': 'https://openalex.org/C2781230642', 'wikidata': 'https://www.wikidata.org/wiki/Q492646', 'display_name': 'Targeted therapy', 'level': 3, 'score': 0.49512926}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.44714224}, {'id': 'https://openalex.org/C146357865', 'wikidata': 'https://www.wikidata.org/wiki/Q1123245', 'display_name': 'Stage (stratigraphy)', 'level': 2, 'score': 0.43977624}, {'id': 'https://openalex.org/C143065580', 'wikidata': 'https://www.wikidata.org/wiki/Q3285695', 'display_name': 'Mutant', 'level': 3, 'score': 0.43278876}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.33550116}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.15034187}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.06649408}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.05425322}, {'id': 'https://openalex.org/C151730666', 'wikidata': 'https://www.wikidata.org/wiki/Q7205', 'display_name': 'Paleontology', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2024-ct271', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.85}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4311167496', 'https://openalex.org/W2994288809', 'https://openalex.org/W2350587855', 'https://openalex.org/W2155835698', 'https://openalex.org/W2094337488', 'https://openalex.org/W2077224613', 'https://openalex.org/W2076096978', 'https://openalex.org/W2047730886', 'https://openalex.org/W2044028228', 'https://openalex.org/W1984834769'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Invasive': [2], 'lobular': [3, 472], 'carcinoma': [4], '(ILC)': [5], 'accounts': [6], 'for': [7, 118, 175, 229, 277, 425, 435, 482], 'approximately': [8], '10-15%': [9], 'of': [10, 27, 55, 76, 121, 196, 205, 217, 243, 256, 297, 306, 387, 407, 442, 478], 'all': [11], 'breast': [12, 125, 141, 281, 298, 370, 450, 473], 'cancers': [13], 'and': [14, 25, 44, 49, 64, 91, 104, 131, 150, 182, 200, 227, 250, 295, 315, 321, 336, 347, 354, 361, 365, 391, 493], 'is': [15, 109, 166, 378], 'characterized': [16], 'by': [17, 191], 'hormone': [18], 'receptor': [19], 'positivity': [20], '(HR+),': [21], 'low': [22, 53], 'Ki-67': [23], 'score,': [24, 267], 'loss': [26], 'cell': [28, 308], 'adhesion': [29], 'receptors': [30], 'such': [31], 'as': [32, 85, 87, 422], 'E-cadherin.': [33], 'While': [34], 'these': [35], 'tumors': [36], 'tend': [37], 'to': [38, 60, 202, 233, 235, 272, 330, 349, 357, 411], 'be': [39, 189, 212, 260, 270, 345], 'indolent': [40], 'initially,': [41], 'late': [42], 'recurrences': [43], 'distant': [45], 'metastasis': [46], 'are': [47, 71, 99], 'common,': [48], 'ILC': [50, 98], 'has': [51, 128], 'very': [52], 'rates': [54, 296], 'pathologic': [56, 154], 'complete': [57], 'response': [58], '(pCR)': [59], 'both': [61], 'neoadjuvant': [62, 146, 285], 'chemotherapy': [63], 'endocrine': [65, 263], 'therapy': [66, 467], '(ET).': [67], 'HER2': [68, 95, 111, 184, 312, 389], '(ERBB2)': [69], 'mutations': [70, 96], 'enriched': [72], 'in': [73, 89, 97, 133, 137, 156, 381, 393, 444, 468], 'about': [74], '10%': [75], 'unselected': [77], 'ILC,': [78], 'with': [79, 101, 135, 148, 178, 279, 284, 446], 'some': [80], 'reports': [81], 'showing': [82], 'the': [83, 197, 215, 218, 240, 261, 319, 327, 341, 436, 439, 479], 'prevalence': [84], 'high': [86], '27%': [88], 'pleomorphic': [90], 'higher': [92], 'grade': [93], 'ILCs.': [94], 'associated': [100], 'ET': [102, 136, 151, 206, 226, 392], 'resistance': [103], 'a': [105, 110, 183, 209, 247, 273, 379, 388, 404, 412, 423], 'worse': [106], 'prognosis.': [107], 'Neratinib': [108], 'tyrosine': [112], 'kinase': [113], 'inhibitor': [114], '(TKI)': [115], 'currently': [116], 'FDA-approved': [117], 'adjuvant': [119], 'treatment': [120, 147, 424], 'HER2-amplified': [122], '(HER2+)': [123], 'early-stage': [124], 'cancer.': [126, 142, 451], 'It': [127], 'shown': [129], 'safety': [130], 'efficacy': [132], 'combination': [134, 386], 'metastatic': [138], 'HER2-mutant': [139, 159, 394, 471], 'HR+': [140, 160, 280, 449], 'We': [143, 396], 'hypothesize': [144], 'that': [145, 368], 'neratinib': [149, 228, 244, 335], 'will': [152, 188, 211, 223, 245, 259, 269, 289, 303, 344], 'improve': [153], 'responses': [155], 'newly': [157, 447], 'diagnosed': [158, 448], 'ILC.': [161, 395, 429], 'Methods:': [162], 'This': [163, 377, 430], 'study': [164, 258, 358, 401], '(NCT05919108)': [165], 'an': [167], 'open': [168], 'label': [169], 'multi-site': [170], 'Phase': [171, 414], 'II': [172], 'clinical': [173, 408], 'trial': [174, 416], '30': [176], 'patients': [177, 222, 278, 445], 'Stage': [179], 'I-III': [180, 470], 'ILCs': [181], 'activating': [185], 'mutation.': [186], 'Patients': [187], 'identified': [190], 'next': [192], 'generation': [193], 'sequencing': [194, 356], '(NGS)': [195], 'diagnostic': [198], 'biopsy': [199, 210, 325], 'randomized': [201, 413], '4': [203], 'weeks': [204, 231], '+/-': [207], 'neratinib;': [208], 'done': [213], 'at': [214, 418], 'end': [216], 'lead-in': [219, 328], 'phase.': [220], 'All': [221], 'then': [224], 'receive': [225], '20': [230], 'prior': [232], 'proceeding': [234], 'surgery.': [236, 300], 'To': [237], 'optimize': [238], 'tolerability,': [239], 'first': [241, 380, 437], 'cycle': [242, 309], 'include': [246, 290, 304], 'dose': [248], 'escalation': [249], 'antidiarrheal': [251], 'prophylaxis.': [252], 'The': [253], 'primary': [254], 'objective': [255], 'this': [257, 400], 'pre-operative': [262], 'prognostic': [264], 'index': [265], '(PEPI)': [266], 'which': [268], 'compared': [271], 'historical': [274], 'PEPI-0': [275], 'rate': [276], 'cancer': [282, 293, 371, 474], 'treated': [283], 'ET.': [286, 337], 'Secondary': [287], 'objectives': [288], 'pCR,': [291], 'residual': [292], 'burden,': [294], 'conserving': [299], 'Correlative': [301], 'studies': [302], 'biomarkers': [305], 'tumor': [307, 359], 'arrest,': [310], 'apoptosis,': [311], 'pathway': [313], 'activation,': [314], 'gene': [316], 'expression': [317], 'on': [318], 'pre-': [320], 'on-treatment': [322], '(4': [323], 'week)': [324], 'from': [326, 340, 399], 'phase': [329], 'document': [331], 'molecular': [332], 'synergy': [333], 'between': [334], 'Patient-derived': [338], 'organoids': [339], '4-week': [342], 'biopsies': [343], 'established': [346], 'subjected': [348], 'single-cell': [350], 'RNA,': [351], 'ATAC': [352], 'seq,': [353], 'DNA': [355], 'evolution': [360], 'elucidate': [362], 'epigenetic': [363], 'programs': [364], 'somatic': [366], 'alterations': [367], 'allow': [369], 'survival': [372], 'despite': [373], 'continuous': [374], 'HER2-directed': [375, 420], 'therapy.': [376], 'kind,': [382], 'mechanism-based,': [383], 'molecularly': [384], 'targeted': [385, 466], 'TKI': [390], 'posit': [397], 'results': [398], 'may': [402, 432], 'generate': [403], 'clear': [405], 'signal': [406, 431], 'activity': [409], 'leading': [410], 'III': [415], 'aimed': [417], 'incorporating': [419], 'therapies': [421], 'operable,': [426], 'early': [427], 'stage': [428, 469], 'also': [433], 'suggest': [434], 'time': [438], 'added': [440], 'value': [441], 'NGS': [443], 'Citation': [452], 'Format:': [453], 'Laura': [454], 'C.': [455], 'Kennedy,': [456], 'Nisha': [457], 'Unni,': [458], 'Ariella': [459], 'B.': [460], 'Hanker,': [461], 'Carlos': [462], 'L.': [463], 'Arteaga.': [464], 'Neoadjuvant': [465], '[abstract].': [475], 'In:': [476], 'Proceedings': [477], 'American': [480], 'Association': [481], 'Cancer': [483, 505], 'Research': [484], 'Annual': [485], 'Meeting': [486], '2024;': [487], 'Part': [488], '2': [489], '(Late-Breaking,': [490], 'Clinical': [491], 'Trial,': [492], 'Invited': [494], 'Abstracts);': [495], '2024': [496], 'Apr': [497], '5-10;': [498], 'San': [499], 'Diego,': [500], 'CA.': [501], 'Philadelphia': [502], '(PA):': [503], 'AACR;': [504], 'Res': [506], '2024;84(7_Suppl):Abstract': [507], 'nr': [508], 'CT271.': [509]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4393989242', 'counts_by_year': [], 'updated_date': '2024-12-12T08:29:59.250537', 'created_date': '2024-04-06'}